|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.47 USD | +3.22% |
|
-13.40% | -25.39% |
| Market Cap | 7.56B 10.13B 8.77B 8.08B 14.11B 965B 14.43B 96.02B 37.24B 467B 38.02B 37.21B 1,625B | P/E Ratio 2026 * |
-11.5x | P/E Ratio 2027 * | -11.6x |
|---|---|---|---|---|---|
| Enterprise Value | 7.3B 9.78B 8.46B 7.8B 13.62B 932B 13.93B 92.69B 35.95B 451B 36.71B 35.92B 1,569B | EV / Sales 2026 * |
2,979x | EV / Sales 2027 * | 180x |
| Free-Float |
17.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Summit Therapeutics Inc.
| 1 day | +3.56% | ||
| 1 week | -13.40% | ||
| Current month | -25.60% | ||
| 1 month | -27.82% | ||
| 3 months | -20.09% | ||
| 6 months | -27.26% | ||
| Current year | -25.39% |
| 1 week | 12.55 |  | 15.35 |
| 1 month | 12.55 | | 19.08 |
| Current year | 12.55 | | 29.23 |
| 1 year | 12.55 | | 30.98 |
| 3 years | 1.52 | | 36.91 |
| 5 years | 0.66 | | 36.91 |
| 10 years | 0.66 | | 36.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 54 | 24/07/2022 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 31/03/2020 |
| Director of Finance/CFO | 48 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 31/01/2020 |
| Director/Board Member | 48 | 30/11/2019 | |
Mahkam Zanganeh
BRD | Director/Board Member | 54 | 10/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-03 | Buy | Chief Financial Officer | 50,000 | 0.0064% | ||
| 06-03 | Other | Chief Executive Officer | 0 | 0% | ||
| 06-03 | Buy | Chief Executive Officer | 100,000 | 0.0129% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.22% | -13.40% | -40.90% | +645.71% | 10.13B | |
| -0.21% | +4.39% | +50.24% | +105.62% | 54.82B | |
| +3.81% | -1.83% | +49.52% | +43.89% | 43.27B | |
| +0.41% | -2.60% | -19.40% | -21.14% | 21.79B | |
| +1.32% | -11.53% | +1.04% | +364.04% | 19.92B | |
| +0.81% | -7.65% | +12.35% | -32.11% | 15.67B | |
| +0.05% | +2.12% | +8.93% | -40.11% | 15.26B | |
| +0.47% | +1.90% | +23.66% | +173.85% | 13.22B | |
| -0.40% | +9.68% | +101.51% | +225.17% | 11.58B | |
| -1.74% | +1.08% | +14.99% | - | 11.94B | |
| Average | +0.68% | -1.34% | +20.19% | +162.77% | 21.76B | |
| Weighted average by Cap. | +0.88% | +0.73% | +27.93% | +120.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.45M 3.28M 2.84M 2.62M 4.57M 313M 4.67M 31.11M 12.07M 151M 12.32M 12.06M 527M | 42.03M 56.31M 48.73M 44.93M 78.43M 5.36B 80.19M 534M 207M 2.6B 211M 207M 9.03B |
| Net income | -657M -880M -761M -702M -1.23B -83.82B -1.25B -8.34B -3.23B -40.59B -3.3B -3.23B -141B | -680M -911M -788M -727M -1.27B -86.78B -1.3B -8.63B -3.35B -42.02B -3.42B -3.35B -146B |
| Net Debt | -262M -351M -303M -280M -488M -33.4B -499M -3.32B -1.29B -16.18B -1.32B -1.29B -56.25B | -11.05M -14.8M -12.81M -11.81M -20.62M -1.41B -21.08M -140M -54.42M -683M -55.56M -54.37M -2.37B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/06/26 | 13.05 $ | -8.68% | 8,628,130 |
| 09/06/26 | 14.29 $ | +1.28% | 5,034,913 |
| 08/06/26 | 14.11 $ | -4.47% | 5,493,064 |
| 05/06/26 | 14.77 $ | -0.47% | 6,516,701 |
| 04/06/26 | 14.84 $ | -1.53% | 5,414,589 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SMMT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition